These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 31375596

  • 1. Modified Vaccinia Virus Ankara Can Induce Optimal CD8+ T Cell Responses to Directly Primed Antigens Depending on Vaccine Design.
    Wong YC, Croft S, Smith SA, Lin LCW, Cukalac T, La Gruta NL, Drexler I, Tscharke DC.
    J Virol; 2019 Nov 01; 93(21):. PubMed ID: 31375596
    [Abstract] [Full Text] [Related]

  • 2. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
    Baur K, Brinkmann K, Schweneker M, Pätzold J, Meisinger-Henschel C, Hermann J, Steigerwald R, Chaplin P, Suter M, Hausmann J.
    J Virol; 2010 Sep 01; 84(17):8743-52. PubMed ID: 20538860
    [Abstract] [Full Text] [Related]

  • 3. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
    Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.
    PLoS One; 2009 Sep 01; 4(5):e5445. PubMed ID: 19421328
    [Abstract] [Full Text] [Related]

  • 4. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE, Rodríguez D, Rodríguez JR, Abaitua F, Duarte C, Esteban M.
    Vaccine; 2001 Dec 12; 20(5-6):961-71. PubMed ID: 11738764
    [Abstract] [Full Text] [Related]

  • 5. Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c mice.
    Russell TA, Tscharke DC.
    Immunol Cell Biol; 2014 Dec 12; 92(5):466-9. PubMed ID: 24566805
    [Abstract] [Full Text] [Related]

  • 6. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ, Pérez P, Ljungberg K, Sorzano CÓS, Gómez CE, Liljeström P, Esteban M, García-Arriaza J.
    J Virol; 2019 Apr 01; 93(7):. PubMed ID: 30674625
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
    Staib C, Kisling S, Erfle V, Sutter G.
    J Gen Virol; 2005 Jul 01; 86(Pt 7):1997-2006. PubMed ID: 15958679
    [Abstract] [Full Text] [Related]

  • 11. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
    Volz A, Langenmayer M, Jany S, Kalinke U, Sutter G.
    J Virol; 2014 Sep 01; 88(18):10946-57. PubMed ID: 25008931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
    Di Mario G, Sciaraffia E, Facchini M, Gubinelli F, Soprana E, Panigada M, Bernasconi V, Garulli B, Siccardi A, Donatelli I, Castrucci MR.
    Pathog Glob Health; 2017 Mar 01; 111(2):76-82. PubMed ID: 28079473
    [Abstract] [Full Text] [Related]

  • 16. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF, van de Sandt CE, van Trierum SE, De Gruyter HLM, van Run PRWA, Fouchier RAM, Roose K, Saelens X, Volz A, Sutter G, de Vries RD, Rimmelzwaan GF.
    J Virol; 2016 Nov 15; 90(22):10209-10219. PubMed ID: 27581985
    [Abstract] [Full Text] [Related]

  • 17. Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.
    Sánchez-Sampedro L, Gómez CE, Mejías-Pérez E, Pérez-Jiménez E, Oliveros JC, Esteban M.
    J Virol; 2013 Jun 15; 87(12):6955-74. PubMed ID: 23596295
    [Abstract] [Full Text] [Related]

  • 18. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.
    Iborra S, Izquierdo HM, Martínez-López M, Blanco-Menéndez N, Reis e Sousa C, Sancho D.
    J Clin Invest; 2012 May 15; 122(5):1628-43. PubMed ID: 22505455
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine.
    Lopera-Madrid J, Osorio JE, He Y, Xiang Z, Adams LG, Laughlin RC, Mwangi W, Subramanya S, Neilan J, Brake D, Burrage TG, Brown WC, Clavijo A, Bounpheng MA.
    Vet Immunol Immunopathol; 2017 Mar 15; 185():20-33. PubMed ID: 28241999
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.